Cargando…
Nonalcoholic Fatty Liver Disease and the Kidney: A Review
Nonalcoholic fatty liver disease (NAFLD) is associated with several extrahepatic manifestations such as cardiovascular disease and sleep apnea. Furthermore, NAFLD is reported to be associated with an increased risk of incident chronic kidney disease (CKD). Inflammation and oxidative stress are sugge...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533178/ https://www.ncbi.nlm.nih.gov/pubmed/34680486 http://dx.doi.org/10.3390/biomedicines9101370 |
_version_ | 1784587248958701568 |
---|---|
author | Umbro, Ilaria Baratta, Francesco Angelico, Francesco Del Ben, Maria |
author_facet | Umbro, Ilaria Baratta, Francesco Angelico, Francesco Del Ben, Maria |
author_sort | Umbro, Ilaria |
collection | PubMed |
description | Nonalcoholic fatty liver disease (NAFLD) is associated with several extrahepatic manifestations such as cardiovascular disease and sleep apnea. Furthermore, NAFLD is reported to be associated with an increased risk of incident chronic kidney disease (CKD). Inflammation and oxidative stress are suggested to be the key factors involved in the inflammatory mechanisms and pathways linking NAFLD to CKD and are responsible for both the pathogenesis and the progression of CKD in NAFLD patients. This review aims to provide a more comprehensive overview of the association between CKD and NAFLD, also considering the effect of increasing severity of NAFLD. A PubMed search was conducted using the terms “non-alcoholic fatty liver disease AND kidney”. In total, 537 articles were retrieved in the last five years and 12 articles were included in the qualitative analysis. Our results showed that CKD developed more frequently in NAFLD patients compared to those without NAFLD. This association persisted after adjustment for traditional risk factors and according to the severity of NAFLD. Therefore, patients with NAFLD should be considered at high risk of CKD. Intensive multidisciplinary surveillance over time is needed, where hepatologists and nephrologists must act together for better and earlier treatment of NAFLD patients. |
format | Online Article Text |
id | pubmed-8533178 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-85331782021-10-23 Nonalcoholic Fatty Liver Disease and the Kidney: A Review Umbro, Ilaria Baratta, Francesco Angelico, Francesco Del Ben, Maria Biomedicines Review Nonalcoholic fatty liver disease (NAFLD) is associated with several extrahepatic manifestations such as cardiovascular disease and sleep apnea. Furthermore, NAFLD is reported to be associated with an increased risk of incident chronic kidney disease (CKD). Inflammation and oxidative stress are suggested to be the key factors involved in the inflammatory mechanisms and pathways linking NAFLD to CKD and are responsible for both the pathogenesis and the progression of CKD in NAFLD patients. This review aims to provide a more comprehensive overview of the association between CKD and NAFLD, also considering the effect of increasing severity of NAFLD. A PubMed search was conducted using the terms “non-alcoholic fatty liver disease AND kidney”. In total, 537 articles were retrieved in the last five years and 12 articles were included in the qualitative analysis. Our results showed that CKD developed more frequently in NAFLD patients compared to those without NAFLD. This association persisted after adjustment for traditional risk factors and according to the severity of NAFLD. Therefore, patients with NAFLD should be considered at high risk of CKD. Intensive multidisciplinary surveillance over time is needed, where hepatologists and nephrologists must act together for better and earlier treatment of NAFLD patients. MDPI 2021-10-01 /pmc/articles/PMC8533178/ /pubmed/34680486 http://dx.doi.org/10.3390/biomedicines9101370 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Umbro, Ilaria Baratta, Francesco Angelico, Francesco Del Ben, Maria Nonalcoholic Fatty Liver Disease and the Kidney: A Review |
title | Nonalcoholic Fatty Liver Disease and the Kidney: A Review |
title_full | Nonalcoholic Fatty Liver Disease and the Kidney: A Review |
title_fullStr | Nonalcoholic Fatty Liver Disease and the Kidney: A Review |
title_full_unstemmed | Nonalcoholic Fatty Liver Disease and the Kidney: A Review |
title_short | Nonalcoholic Fatty Liver Disease and the Kidney: A Review |
title_sort | nonalcoholic fatty liver disease and the kidney: a review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533178/ https://www.ncbi.nlm.nih.gov/pubmed/34680486 http://dx.doi.org/10.3390/biomedicines9101370 |
work_keys_str_mv | AT umbroilaria nonalcoholicfattyliverdiseaseandthekidneyareview AT barattafrancesco nonalcoholicfattyliverdiseaseandthekidneyareview AT angelicofrancesco nonalcoholicfattyliverdiseaseandthekidneyareview AT delbenmaria nonalcoholicfattyliverdiseaseandthekidneyareview |